Bright Futures and Genomic Duties
By Jonathan Kahn, Biopolitical Times guest contributor
| 04. 20. 2011
A recent issue of Nature reviewed the accomplishments of the Human Genome Project 10 years after the grand announcement of the completion of the first draft of the human genome. With a cover declaring "The Future is Bright," the issue featured an article by Eric Green, the new director of National Human Genome Research Institute, and others [pdf] that was intended to "articulate a 2011 vision for the future of genomics research and describe the path towards an era of genomic medicine."
Understandably, the authors accentuate the positive and express both hope and enthusiasm for the future of genomic research. To realize the great promise of ongoing genomic research, they also identify several "imperatives for genomic medicine," specifically:
- Making genomics-based diagnostics routine
- Defining the genetic components of disease
- Comprehensive characterization of cancer genomes
- Practical systems for clinical genomic informatics
- The role of the human microbiome in health and disease
These are relatively unexceptional goals and certainly worthy of pursuit. To propel genomic research down this path, however, the authors also declare that "Effective genomics research needs continual, broad...
Related Articles
GeneWatch UK has prepared a briefing on the genetic modification of nature for the International Union for Conservation of Nature (IUCN) Congress in October 2025
The upcoming Congress claims to be “where the world comes together to set priorities and drive conservation and sustainable development action.” A major concern for those on the outside is that the Congress may advance plans to develop and encourage the use of synthetic biology in nature conservation. This could at first glance sound like...
By Aaron Ginn, The Washington Post | 09.12.2025
Earlier this year, I had dinner in D.C. with Jensen Huang, the president and chief executive of Nvidia. At one point, he said something that struck me: “Why is everyone here so negative?”
He wasn’t referring to the economy...
By Roni Caryn Rabin, The New York Times | 08.25.2025
Scientists have dreamed for centuries about using animal organs to treat ailing humans. In recent years, those efforts have begun to bear fruit: Researchers have begun transplanting the hearts and kidneys of genetically modified pigs into patients, with varying degrees...
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...
